by The dental membrane and bone graft substitute market is estimated to be valued at US$ 1143.56 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Dental membrane and bone graft substitutes are used for guided bone regeneration, preservation of alveolar bone and augment grafting site for dental implants. The membrane acts as a physical barrier preventing the soft tissues from growing into the bony reconstruction site, allowing new bone to form. Bone graft substitutes aid in new bone formation by providing scaffold for osteogenic cells to attach, differentiate and deposit new bone minerals. They can be bioabsorbable or non-resorbable based on application.
Market Dynamics:
Increasing prevalence of dental diseases and trauma injuries has propelled demand for dental care across globally. As per data by World Health Organization (WHO), oral diseases affect nearly 3.5 billion people worldwide and almost 486 million children suffer from dental cavities. Further rising geriatric population which is more susceptible to dental issues will further drive the market growth. Rising awareness regarding dental care and availability of advanced dental treatments has resulted in increased use of dental membrane and bone graft substitutes for oral surgeries such as ridge augmentation, socket preservation and guided bone regeneration. Additionally, favorable reimbursement for dental procedures in developed nations supplement the market growth over forecast period.
Segment Analysis
The dental membrane and bone graft substitute market is segmented into synthetic bone grafts, xenografts, allografts, and BMPs. Among these, the allografts segment holds the largest share in the market owing to its extensive usage in dental and maxillofacial procedures due to their biocompatibility. Allografts are preferred over other substitutes as they minimize donor site morbidity and avoid disease transmission.
PEST Analysis
Political: Governments across countries are focused on improvising healthcare infrastructure and providing reimbursement coverage for dental surgeries involving bone grafts which is propelling market growth.
Economic: The rising per capita healthcare expenditure and disposable incomes have led to an increase in dental cosmetic procedures which present an opportunity for bone graft substitutes.
Social: Growing awareness about the availability of bone grafting techniques for treating dental defects is driving the demand.
Technological: Advancements in bone grafting biomaterials and membranes have made procedures more predictable and reliable boosting their uptake.
Key Takeaways
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing prevalence of dental diseases, rising focus on dental aesthetics, and launch of advanced biomaterial-based grafting solutions.
The North American region is projected to dominate the market during the analysis period led by the U.S. due to well-established healthcare systems, presence of key players, and growing demand for dental cosmetic procedures in the region.
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.
Regional analysis
The North American region is projected to dominate the dental membrane and bone graft substitute market during the forecast period owing to rising dental expenditure, availability of advanced treatment options and presence of key industry players in the region. The United States represents the largest market in North America due to increased awareness about oral healthcare and availability of reimbursement for dental bone grafting procedures in the country.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
